Our top pick for
Blackmores is a packaged foods business based in Australia. Blackmores shares (BKL) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Blackmores has a trailing 12-month revenue of around $645 million. If you're looking to buy shares, check out the steps below.
|52-week range||$66.0348 - $94.73|
|50-day moving average||$94.4644|
|200-day moving average||$83.0339|
|Dividend yield||$1.19 (1.26%)|
|Earnings per share (TTM)||$1.76|
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|6 months (2023-06-05)||0.51%|
|1 year (2022-12-05)||33.57%|
|2 years (2021-12-03)||6.32%|
|3 years (2020-12-04)||18.80%|
|5 years (2018-12-05)||-24.05%|
Valuing Blackmores stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Blackmores's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Blackmores's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 54x. In other words, Blackmores shares trade at around 54x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Blackmores's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $70.1 million (£0.0 million).
The EBITDA is a measure of a Blackmores's overall financial performance and is widely used to measure stock profitability.
|Revenue TTM||$645 million|
|Operating margin TTM||8.52%|
|Gross profit TTM||$403.4 million|
|Return on assets TTM||5.84%|
|Return on equity TTM||9.36%|
|Market capitalisation||$1.8 billion|
TTM: trailing 12 months
Dividend payout ratio: 3.38% of net profits
Recently Blackmores has paid out, on average, around 3.38% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.84% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Blackmores shareholders could enjoy a 1.84% return on their shares, in the form of dividend payments. In Blackmores's case, that would currently equate to about A$1.19 per share.
While Blackmores's payout ratio might seem low, this can signify that Blackmores is investing more in its future growth.
The latest dividend was paid out to all shareholders who bought their shares by 25 July 2023 (the "ex-dividend date").
Blackmores's shares were split on a 1.0286:1 basis on 1 November 1991. So if you had owned 1 share the day before the split, the next day you would own 1.0286 shares. This wouldn't directly have changed the overall worth of your Blackmores shares – just the quantity. However, indirectly, the new 2.8% lower share price could have impacted the market appetite for Blackmores shares which in turn could have impacted Blackmores's share price.
Over the last 12 months, Blackmores's shares have ranged in value from as little as $66.0348 up to $94.73. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Blackmores's is 0.6147. This would suggest that Blackmores's shares are less volatile than average (for this exchange).
Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and India. The company offers vitamins, and herbal and mineral nutritional supplements. It also provides products for various conditions related to arthritis, joints, bones, and muscles; brain health; cold, flu, and immunity; digestive health; energy and exercise; everyday health; and eye health. In addition, the company offers products in the areas of fish and nutritional oils; heart and circulation; infant nutrition; kids health; men's health; multivitamins; nails, hair, and skin; pet health; probiotics; pregnancy and preconception; stress relief and sleep support; weight management; wellbeing management; and women's health. It provides its products through retail and online channels. The company was founded in 1930 and is headquartered in Sydney, Australia.
What you need to know about investing in Shein from Australia.
Looking for the best performing stocks in Australia? We update this list weekly.
If you're thinking of trading stocks with Tiger Brokers, check out our review of this online broker's fees, safety and pros and cons first.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Steps to owning and managing Caltex Australia shares from .
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
Learn about the money market and everyday consumer money market products.
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
Follow these tips to find the best share trading platform for you.